Mirzotamab (Anti-B7-H3 / CD276)
Mirzotamab (Anti-B7-H3 / CD276) is a human IgG1κ monoclonal antibody targeting CD276/B7-H3. Mirzotamab is used to produce Mirzotamab clezutoclax antibody drug conjugate (ADC). MW: 144.86 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2935 |
Sku # | A2935-1mg*5 |
Pricing | 1mg*5, $970.00 |